Table 2.
Hazard ratios (±95%CI) between presence or absence of variable of interest Bolded values for comparisons have p<0.05
| Variable | TACE (95% CI) | Y90 (95% CI) |
|---|---|---|
| Demographics | ||
| Males vs. Females | 1.29(1.07–1.55) | 1.63(0.99–2.69) |
| Heavy Alcohol | 1.32(1.08–1.63) | 1.72(0.98–3.01) |
| Heavy Tobacco | 1.20(0.90–1.61) | 2.47(1.17–5.25) |
| Concomitant Liver Disease | ||
| HBV only | 0.77(0.61–0.98) | 2.75(1.31–5.78) |
| HCV only | 1.21(0.98–1.57) | 1.28(0.76–2.16) |
| Cirrhosis (any cause) | 1.50(1.25–1.81) | 1.96(1.02–3.69) |
| Tumor Characteristics | ||
| Tumor Size ≥5 cm | 1.17(0.90–1.38) | 0.78(0.41–1.50) |
| Tumor Number ≥5 | 1.06(0.88–1.3) | 1.8(1.01–3.21) |
| Portal Vein Thrombosis | 1.31(1.11–1.54) | 2.13(1.33–3.39) |
| Alpha-fetoprotein ≥25 ng/ml | 1.56(1.30–1.88) | 1.71(1.09–2.70) |
| Liver Function | ||
| Bilirubin ≥1.5 mg/dL | 1.55(1.29–1.86) | 2.69(1.44–5.04) |
| Albumin <3.5 g/dL | 1.48(1.22–1.78) | 2.03(1.25–3.31) |